 | • レポートコード：MRC2-11QY09184 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はロタウイルス感染症治療薬のグローバル市場について調査・分析したレポートです。種類別（RV-3BB、RV-625、UMN-2001、Rotavac-5C、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ロタウイルス感染症治療薬の競争状況、市場シェア ・世界のロタウイルス感染症治療薬市場：種類別市場規模 2015年-2020年（RV-3BB、RV-625、UMN-2001、Rotavac-5C、その他） ・世界のロタウイルス感染症治療薬市場：種類別市場規模予測 2021年-2026年（RV-3BB、RV-625、UMN-2001、Rotavac-5C、その他） ・世界のロタウイルス感染症治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のロタウイルス感染症治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のロタウイルス感染症治療薬市場分析：米国、カナダ ・ヨーロッパのロタウイルス感染症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのロタウイルス感染症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のロタウイルス感染症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのロタウイルス感染症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Beijing Minhai Biotechnology Co Ltd、Bharat Biotech International Ltd、Biological E Ltd、Curevac AG、Medicago Inc、Nanotherapeutics Inc、Serum Institute of India Ltd、UMN Pharma Inc、Wuhan Institute of Biological Products Co Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Rotavirus Infections Drug Market
The global Rotavirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Rotavirus Infections Drug Scope and Market Size
Rotavirus Infections Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rotavirus Infections Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Rotavirus Infections Drug market is segmented into
RV-3BB
RV-625
UMN-2001
Rotavac-5C
Others
Segment by Application, the Rotavirus Infections Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Rotavirus Infections Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Rotavirus Infections Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Rotavirus Infections Drug Market Share Analysis
Rotavirus Infections Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Rotavirus Infections Drug business, the date to enter into the Rotavirus Infections Drug market, Rotavirus Infections Drug product introduction, recent developments, etc.
The major vendors covered:
Beijing Minhai Biotechnology Co Ltd
Bharat Biotech International Ltd
Biological E Ltd
Curevac AG
Medicago Inc
Nanotherapeutics Inc
Serum Institute of India Ltd
UMN Pharma Inc
Wuhan Institute of Biological Products Co Ltd
1 Study Coverage
1.1 Rotavirus Infections Drug Product Introduction
1.2 Market Segments
1.3 Key Rotavirus Infections Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Rotavirus Infections Drug Market Size Growth Rate by Type
1.4.2 RV-3BB
1.4.3 RV-625
1.4.4 UMN-2001
1.4.5 Rotavac-5C
1.4.6 Others
1.5 Market by Application
1.5.1 Global Rotavirus Infections Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Rotavirus Infections Drug Market Size, Estimates and Forecasts
2.1.1 Global Rotavirus Infections Drug Revenue 2015-2026
2.1.2 Global Rotavirus Infections Drug Sales 2015-2026
2.2 Global Rotavirus Infections Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Rotavirus Infections Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Rotavirus Infections Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Rotavirus Infections Drug Competitor Landscape by Players
3.1 Rotavirus Infections Drug Sales by Manufacturers
3.1.1 Rotavirus Infections Drug Sales by Manufacturers (2015-2020)
3.1.2 Rotavirus Infections Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Rotavirus Infections Drug Revenue by Manufacturers
3.2.1 Rotavirus Infections Drug Revenue by Manufacturers (2015-2020)
3.2.2 Rotavirus Infections Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Rotavirus Infections Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Rotavirus Infections Drug Revenue in 2019
3.2.5 Global Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Rotavirus Infections Drug Price by Manufacturers
3.4 Rotavirus Infections Drug Manufacturing Base Distribution, Product Types
3.4.1 Rotavirus Infections Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Rotavirus Infections Drug Product Type
3.4.3 Date of International Manufacturers Enter into Rotavirus Infections Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Rotavirus Infections Drug Market Size by Type (2015-2020)
4.1.1 Global Rotavirus Infections Drug Sales by Type (2015-2020)
4.1.2 Global Rotavirus Infections Drug Revenue by Type (2015-2020)
4.1.3 Rotavirus Infections Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Rotavirus Infections Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Rotavirus Infections Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Rotavirus Infections Drug Revenue Forecast by Type (2021-2026)
4.2.3 Rotavirus Infections Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Rotavirus Infections Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Rotavirus Infections Drug Market Size by Application (2015-2020)
5.1.1 Global Rotavirus Infections Drug Sales by Application (2015-2020)
5.1.2 Global Rotavirus Infections Drug Revenue by Application (2015-2020)
5.1.3 Rotavirus Infections Drug Price by Application (2015-2020)
5.2 Rotavirus Infections Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Rotavirus Infections Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Rotavirus Infections Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Rotavirus Infections Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Rotavirus Infections Drug by Country
6.1.1 North America Rotavirus Infections Drug Sales by Country
6.1.2 North America Rotavirus Infections Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Rotavirus Infections Drug Market Facts & Figures by Type
6.3 North America Rotavirus Infections Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Rotavirus Infections Drug by Country
7.1.1 Europe Rotavirus Infections Drug Sales by Country
7.1.2 Europe Rotavirus Infections Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Rotavirus Infections Drug Market Facts & Figures by Type
7.3 Europe Rotavirus Infections Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Rotavirus Infections Drug by Region
8.1.1 Asia Pacific Rotavirus Infections Drug Sales by Region
8.1.2 Asia Pacific Rotavirus Infections Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Rotavirus Infections Drug Market Facts & Figures by Type
8.3 Asia Pacific Rotavirus Infections Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Rotavirus Infections Drug by Country
9.1.1 Latin America Rotavirus Infections Drug Sales by Country
9.1.2 Latin America Rotavirus Infections Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Rotavirus Infections Drug Market Facts & Figures by Type
9.3 Central & South America Rotavirus Infections Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Rotavirus Infections Drug by Country
10.1.1 Middle East and Africa Rotavirus Infections Drug Sales by Country
10.1.2 Middle East and Africa Rotavirus Infections Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Rotavirus Infections Drug Market Facts & Figures by Type
10.3 Middle East and Africa Rotavirus Infections Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
11.2 Bharat Biotech International Ltd
11.2.1 Bharat Biotech International Ltd Corporation Information
11.2.2 Bharat Biotech International Ltd Description and Business Overview
11.2.3 Bharat Biotech International Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bharat Biotech International Ltd Rotavirus Infections Drug Products Offered
11.2.5 Bharat Biotech International Ltd Related Developments
11.3 Biological E Ltd
11.3.1 Biological E Ltd Corporation Information
11.3.2 Biological E Ltd Description and Business Overview
11.3.3 Biological E Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biological E Ltd Rotavirus Infections Drug Products Offered
11.3.5 Biological E Ltd Related Developments
11.4 Curevac AG
11.4.1 Curevac AG Corporation Information
11.4.2 Curevac AG Description and Business Overview
11.4.3 Curevac AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Curevac AG Rotavirus Infections Drug Products Offered
11.4.5 Curevac AG Related Developments
11.5 Medicago Inc
11.5.1 Medicago Inc Corporation Information
11.5.2 Medicago Inc Description and Business Overview
11.5.3 Medicago Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Medicago Inc Rotavirus Infections Drug Products Offered
11.5.5 Medicago Inc Related Developments
11.6 Nanotherapeutics Inc
11.6.1 Nanotherapeutics Inc Corporation Information
11.6.2 Nanotherapeutics Inc Description and Business Overview
11.6.3 Nanotherapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Nanotherapeutics Inc Rotavirus Infections Drug Products Offered
11.6.5 Nanotherapeutics Inc Related Developments
11.7 Serum Institute of India Ltd
11.7.1 Serum Institute of India Ltd Corporation Information
11.7.2 Serum Institute of India Ltd Description and Business Overview
11.7.3 Serum Institute of India Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Serum Institute of India Ltd Rotavirus Infections Drug Products Offered
11.7.5 Serum Institute of India Ltd Related Developments
11.8 UMN Pharma Inc
11.8.1 UMN Pharma Inc Corporation Information
11.8.2 UMN Pharma Inc Description and Business Overview
11.8.3 UMN Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 UMN Pharma Inc Rotavirus Infections Drug Products Offered
11.8.5 UMN Pharma Inc Related Developments
11.9 Wuhan Institute of Biological Products Co Ltd
11.9.1 Wuhan Institute of Biological Products Co Ltd Corporation Information
11.9.2 Wuhan Institute of Biological Products Co Ltd Description and Business Overview
11.9.3 Wuhan Institute of Biological Products Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Products Offered
11.9.5 Wuhan Institute of Biological Products Co Ltd Related Developments
11.1 Beijing Minhai Biotechnology Co Ltd
11.1.1 Beijing Minhai Biotechnology Co Ltd Corporation Information
11.1.2 Beijing Minhai Biotechnology Co Ltd Description and Business Overview
11.1.3 Beijing Minhai Biotechnology Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Products Offered
11.1.5 Beijing Minhai Biotechnology Co Ltd Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Rotavirus Infections Drug Market Estimates and Projections by Region
12.1.1 Global Rotavirus Infections Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Rotavirus Infections Drug Revenue Forecast by Regions 2021-2026
12.2 North America Rotavirus Infections Drug Market Size Forecast (2021-2026)
12.2.1 North America: Rotavirus Infections Drug Sales Forecast (2021-2026)
12.2.2 North America: Rotavirus Infections Drug Revenue Forecast (2021-2026)
12.2.3 North America: Rotavirus Infections Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Rotavirus Infections Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Rotavirus Infections Drug Sales Forecast (2021-2026)
12.3.2 Europe: Rotavirus Infections Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Rotavirus Infections Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Rotavirus Infections Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Rotavirus Infections Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Rotavirus Infections Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Rotavirus Infections Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Rotavirus Infections Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Rotavirus Infections Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Rotavirus Infections Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Rotavirus Infections Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Rotavirus Infections Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Rotavirus Infections Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Rotavirus Infections Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Rotavirus Infections Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Rotavirus Infections Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Rotavirus Infections Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Rotavirus Infections Drug Market Segments
Table 2. Ranking of Global Top Rotavirus Infections Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Rotavirus Infections Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of RV-3BB
Table 5. Major Manufacturers of RV-625
Table 6. Major Manufacturers of UMN-2001
Table 7. Major Manufacturers of Rotavac-5C
Table 8. Major Manufacturers of Others
Table 9. Global Rotavirus Infections Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Rotavirus Infections Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Rotavirus Infections Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Rotavirus Infections Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Rotavirus Infections Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Rotavirus Infections Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Rotavirus Infections Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Rotavirus Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Rotavirus Infections Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rotavirus Infections Drug as of 2019)
Table 18. Rotavirus Infections Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Rotavirus Infections Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Rotavirus Infections Drug Price (2015-2020) (USD/Pcs)
Table 21. Rotavirus Infections Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Rotavirus Infections Drug Product Type
Table 23. Date of International Manufacturers Enter into Rotavirus Infections Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Rotavirus Infections Drug Sales Share by Type (2015-2020)
Table 27. Global Rotavirus Infections Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Rotavirus Infections Drug Revenue Share by Type (2015-2020)
Table 29. Rotavirus Infections Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Rotavirus Infections Drug Sales Share by Application (2015-2020)
Table 32. North America Rotavirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Rotavirus Infections Drug Sales Market Share by Country (2015-2020)
Table 34. North America Rotavirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Rotavirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Table 38. North America Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Rotavirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Rotavirus Infections Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Rotavirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Rotavirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Rotavirus Infections Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Rotavirus Infections Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Rotavirus Infections Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Rotavirus Infections Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Rotavirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Rotavirus Infections Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Rotavirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Rotavirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Rotavirus Infections Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Rotavirus Infections Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Rotavirus Infections Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Rotavirus Infections Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Table 72. Beijing Minhai Biotechnology Co Ltd Corporation Information
Table 73. Beijing Minhai Biotechnology Co Ltd Description and Major Businesses
Table 74. Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Beijing Minhai Biotechnology Co Ltd Product
Table 76. Beijing Minhai Biotechnology Co Ltd Recent Development
Table 77. Bharat Biotech International Ltd Corporation Information
Table 78. Bharat Biotech International Ltd Description and Major Businesses
Table 79. Bharat Biotech International Ltd Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bharat Biotech International Ltd Product
Table 81. Bharat Biotech International Ltd Recent Development
Table 82. Biological E Ltd Corporation Information
Table 83. Biological E Ltd Description and Major Businesses
Table 84. Biological E Ltd Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Biological E Ltd Product
Table 86. Biological E Ltd Recent Development
Table 87. Curevac AG Corporation Information
Table 88. Curevac AG Description and Major Businesses
Table 89. Curevac AG Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Curevac AG Product
Table 91. Curevac AG Recent Development
Table 92. Medicago Inc Corporation Information
Table 93. Medicago Inc Description and Major Businesses
Table 94. Medicago Inc Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Medicago Inc Product
Table 96. Medicago Inc Recent Development
Table 97. Nanotherapeutics Inc Corporation Information
Table 98. Nanotherapeutics Inc Description and Major Businesses
Table 99. Nanotherapeutics Inc Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Nanotherapeutics Inc Product
Table 101. Nanotherapeutics Inc Recent Development
Table 102. Serum Institute of India Ltd Corporation Information
Table 103. Serum Institute of India Ltd Description and Major Businesses
Table 104. Serum Institute of India Ltd Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Serum Institute of India Ltd Product
Table 106. Serum Institute of India Ltd Recent Development
Table 107. UMN Pharma Inc Corporation Information
Table 108. UMN Pharma Inc Description and Major Businesses
Table 109. UMN Pharma Inc Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. UMN Pharma Inc Product
Table 111. UMN Pharma Inc Recent Development
Table 112. Wuhan Institute of Biological Products Co Ltd Corporation Information
Table 113. Wuhan Institute of Biological Products Co Ltd Description and Major Businesses
Table 114. Wuhan Institute of Biological Products Co Ltd Rotavirus Infections Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Wuhan Institute of Biological Products Co Ltd Product
Table 116. Wuhan Institute of Biological Products Co Ltd Recent Development
Table 117. Global Rotavirus Infections Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 118. Global Rotavirus Infections Drug Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global Rotavirus Infections Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global Rotavirus Infections Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: Rotavirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 122. North America: Rotavirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: Rotavirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 124. Europe: Rotavirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: Rotavirus Infections Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 126. Asia Pacific: Rotavirus Infections Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: Rotavirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 128. Latin America: Rotavirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: Rotavirus Infections Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 130. Middle East and Africa: Rotavirus Infections Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key Rotavirus Infections Drug Players
Table 135. Rotavirus Infections Drug Customers List
Table 136. Rotavirus Infections Drug Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Rotavirus Infections Drug Product Picture
Figure 2. Global Rotavirus Infections Drug Sales Market Share by Type in 2020 & 2026
Figure 3. RV-3BB Product Picture
Figure 4. RV-625 Product Picture
Figure 5. UMN-2001 Product Picture
Figure 6. Rotavac-5C Product Picture
Figure 7. Others Product Picture
Figure 8. Global Rotavirus Infections Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Rotavirus Infections Drug Report Years Considered
Figure 13. Global Rotavirus Infections Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Rotavirus Infections Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Rotavirus Infections Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Rotavirus Infections Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Rotavirus Infections Drug Sales Market Share by Region in 2019
Figure 18. Global Rotavirus Infections Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Rotavirus Infections Drug Revenue Market Share by Region in 2019
Figure 20. Global Rotavirus Infections Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Rotavirus Infections Drug Revenue in 2019
Figure 22. Rotavirus Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Rotavirus Infections Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Rotavirus Infections Drug Sales Market Share by Type in 2019
Figure 25. Global Rotavirus Infections Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Rotavirus Infections Drug Revenue Market Share by Type in 2019
Figure 27. Global Rotavirus Infections Drug Market Share by Price Range (2015-2020)
Figure 28. Global Rotavirus Infections Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Rotavirus Infections Drug Sales Market Share by Application in 2019
Figure 30. Global Rotavirus Infections Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Rotavirus Infections Drug Revenue Market Share by Application in 2019
Figure 32. North America Rotavirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Rotavirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Rotavirus Infections Drug Sales Market Share by Country in 2019
Figure 35. North America Rotavirus Infections Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Rotavirus Infections Drug Market Share by Type in 2019
Figure 41. North America Rotavirus Infections Drug Market Share by Application in 2019
Figure 42. Europe Rotavirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Rotavirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Rotavirus Infections Drug Sales Market Share by Country in 2019
Figure 45. Europe Rotavirus Infections Drug Revenue Market Share by Country in 2019
Figure 46. Germany Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Rotavirus Infections Drug Market Share by Type in 2019
Figure 57. Europe Rotavirus Infections Drug Market Share by Application in 2019
Figure 58. Asia Pacific Rotavirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Rotavirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Rotavirus Infections Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Rotavirus Infections Drug Revenue Market Share by Region in 2019
Figure 62. China Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Rotavirus Infections Drug Market Share by Type in 2019
Figure 85. Asia Pacific Rotavirus Infections Drug Market Share by Application in 2019
Figure 86. Latin America Rotavirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Rotavirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Rotavirus Infections Drug Sales Market Share by Country in 2019
Figure 89. Latin America Rotavirus Infections Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Rotavirus Infections Drug Market Share by Type in 2019
Figure 97. Latin America Rotavirus Infections Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Rotavirus Infections Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Rotavirus Infections Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Rotavirus Infections Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Rotavirus Infections Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Rotavirus Infections Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Rotavirus Infections Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Rotavirus Infections Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Rotavirus Infections Drug Market Share by Application in 2019
Figure 110. North America Rotavirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Rotavirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Rotavirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Rotavirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Rotavirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Rotavirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Rotavirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Rotavirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Rotavirus Infections Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Rotavirus Infections Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
類鼻疽菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Burkholderia Pseudomallei Infections Drug Market The global Burkholderia Pseudomallei Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Burkholderia Pseudomallei Infec…- ライノウイルス感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Rhinovirus Infections Drug Market The global Rhinovirus Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rhinovirus Infections Drug Scope and Market Size Rhinovirus I…
- ヒトロタウイルスワクチンの世界市場（～2026年） Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two …
- 髄膜炎菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Neisseria meningitidis Infections Drug Market The global Neisseria meningitidis Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neisseria meningitidis Infections Dru…
- A型インフルエンザウイルス・H3N2亜型感染症薬の世界市場（～2026年） Market Analysis and Insights: Global Influenza A Virus, H3N2 Subtype Infections Drug Market The global Influenza A Virus, H3N2 Subtype Infections Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Influenza A Virus, …